Separating fact from fiction: The data behind allergies and side effects caused by penicillins, cephalosporins, and carbapenem antibiotics

Current Pharmaceutical Design

Volumn 9, Issue 12, 2003, Pages 983-988

  Leviton, Ira ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFACLOR; CEPHALOSPORIN DERIVATIVE; METICILLIN; METRONIDAZOLE; NAFCILLIN; OXACILLIN; PENICILLANIC ACID; PENICILLIN DERIVATIVE; PENICILLOYL POLYLYSINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROBENECID; STEROID; SULBACTAM; SULTAMICILLIN; TICARCILLIN; TIMENTIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VANCOMYCIN;

ABDOMINAL PAIN; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBACTERIAL ACTIVITY; ARTHRALGIA; BACTERIAL INFECTION; BRONCHOSPASM; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLITIS; CONTACT DERMATITIS; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG USE; FEVER; FREQUENCY ANALYSIS; HEMOLYTIC ANEMIA; HERXHEIMER REACTION; HUMAN; HYPOKALEMIA; IN VITRO STUDY; INTERSTITIAL NEPHRITIS; LARYNX EDEMA; LYMPHADENOPATHY; MALAISE; METABOLIC ALKALOSIS; NAUSEA AND VOMITING; NEUTROPENIA; PALLOR; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SEIZURE; SERUM SICKNESS; SKIN TEST; STRUCTURE ACTIVITY RELATION; TACHYCARDIA; THROMBOCYTOPENIA; URTICARIA; WHEEZING;

ANIMALS; CARBAPENEMS; CEPHALOSPORINS; DRUG HYPERSENSITIVITY; HUMANS; PENICILLINS;

EID: 0037261195     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033455143     Document Type: Review

References (46)

1. Weiss ME, Adkinson Jr. NF. β-lactam Allergy In: Mandell GL, Bennett JE, Dolin R. (eds) Principles and Practice of Infectious Diseases 5th ed. Churchill Livingstone, Philadelphia Penn 2000; pp 299-305.
2. Smith JM. Med Clin North Amer 1974; 58: 3-24.
3. Horowitz L. New Engl J Med 1975; 292: 1243-1244.
4. Michel J, Sharon R. Brit Med J 1980; 280: 152-153.
5. Kucers A. Penicillin G. In: Kucers A, Crowe S, Grayson ML, Hoy J. (eds) The use of antibiotics, 5th ed, Butterworth Heinemann: Oxford Eng 1997; p 28.
6. Lin RY. Arch Int Med 1992; 152: 930-937.
7. Gadde J, Spence M, Wheeler B, et al. J Amer Med Assoc 1993; 270: 2456-2463.
8. Gell PGH, Coombs RRA. Classification of allergic reactions responsible for clinical hypersensitivity and disease In: PGH Gell RRA Coombs and PJ Hachmann (eds) Clinical Aspects of Immunology Blackwell Scientific Publications: Oxford England 1975; pp 761-781.
9. Arndt KA, Jick H. J Amer Med Assoc 1976; 235: 918-922.
10. Idsoe O, Guthe T, Wilcox RR, de Week, AL. Bull World Health Org 1968; 38: 159-188.
11. Sullivan TJ, Yecies LD, Schatz GS, Parker CW, Wedner HJ. J Allergy Clin Immunol 1982; 69: 272-282.
12. Adkinson Jr. NF, Wheeler B. Risk factors for IgE-dependent reactions to penicillin In: Kerr JW, Ganderton MA (eds) XI International Congress of Allergology and Clinical Immunology MacMillan Publishing London England 1983; pp 55-59.
13. Levine BB. New Engl J Med 1966; 275: 1115-1125.
14. Border WA, Lehman DH, Egan JD, Sass HJ, Glode JE, Wilson CB. New Engl J Med 1974; 291: 381-384.
15. Baldwin DS, Levine BB, McCluskey RT, Gallo GR. New Engl J Med 1968; 279: 1245-1252.
16. Galpin JE, Shinaberger JH, Stanley TM, Blumenkrantz MJ, Bayer AS, Friedman GS, et al. Amer J Med 1978; 65: 756-765.
17. Kerr RO, Cardamone J, Dalmasso AP, Kaplan ME. New Engl J Med 1972; 287: 1322-1325.
18. Parker CW. New Engl J Med 1975; 292: 511-514, 732-736 and 957-960.
19. Young EJ, Fainstein V, Musher DM. Rev Infect Dis 1982; 4: 69-77.
20. Report of a Collaborative Study Group. Brit Med J 1973; 1: 7-9.
21. Levine B. New Engl J Med 1972; 286: 42-43.
22. Shapiro S, Siskind V, Slone D, Lewis GP, Jick H. Lancet 1969; 2: 969-972.
23. Kerns DL, Shira JE, Go S, Summer RJ, Schwab JA, Plunket DC . Amer J Dis Child 1973; 125: 187-190.
24. Kluge RM, Waldman RH, Delafuente JC, Slavin RG. J Infect Dis 1982; 145: 397.
25. Gurwith MJ, Rabin HR, Love K. J Infect Dis 1977; 135 (Supp): 104-110.
26. Snavely SR, Hodges GR. Ann Intern Med 1984; 101: 92-104.
27. Appel GB, Neu HC. New Engl J Med 1993; 296: 663-670, 722-728, 784-787.
28. Griffin GE. J Antimicrob Chemother 1992; 29: 613-616.
29. Gelfand JA, Elin RJ, Berry Jr. FW, Frank MM. New Engl J Med 1976; 295: 211-213.
30. Idsoe O, Guthe T, Wilcox RR. Bull World Health Org 1972; 47 (Supp): 1-68.
31. Croydon P. Worldwide clinical review of Augmentin. In: Postraduate Medicine. Custom Communications New York 1984; 71.
32. Kuye O, Teal J, De Vries VG, Morrow CA, Tally FP. J Antimicrob Chemother 1993; 31 (Supp A): 113-124.
33. Foulds G, Stankewich JP, Marshall DC, O'Brien MM, Hayes SL, Weidler DJ, et al. Antimicrob Agents Chemother 1986; 23: 692-699.
34. Saxon A, Bneall GN, Rohr AS, Adelman DC. Ann Intern Med, 1987; 107: 204-215.
35. Petz L. J Infect Dis 1978; 137: S74-S79.
36. Shibata K, Atsumi T, Horiuchi Y, Mashimo K. Nature 1966; 212: 419-420.
37. Grieco MH. Arch Intern Med 1967; 119: 141-146.
38. Heckbert SR, Stryker WS, Coltin KL, Manson JE, Platt R. Am J Epidemiol 1990; 132: 336-342.
39. Buening MK, Wold JS, Israel KS, Krammer RB. J Amer Med Assoc 1981; 245: 2027.
40. Foster RS, Raehl CL, Wilson HD. Amer J Hosp Pharm 1980; 37: 858-859.
41. Lopez AJ, O'Keefe P, Morrissey M, Pickelman J. Ann Int Med 1991; 115: 712-714.
42. Park HZ, Lee SP, Schy AL. Gastroenterol 1991; 100: 1665-1970.
43. Saxon A, Hassner A, Swabb EA, Wheeler B, Adkinson Jr. NF. J Infect Dis 1984; 149: 16-22.
44. Bhanot SK, Singh M, Chatterjee NR. Curr Pharm Des 2001; 7(5): 311-35.
45. Pag U, Sahl HG. Curr Pharm Des 2002; 8(9): 815-33.
46. Pullerits T. Curr Pharm Des 2002; 8(20): 1845-53.